Cargando…

Comparison of efficacy, safety, and cost-effectiveness of rupatadine and olopatadine in patients of allergic rhinitis: A prospective, randomized, double-blind, parallel group study

OBJECTIVE: To compare the efficacy, safety, and cost-effectiveness of rupatadine and olopatadine in patients of allergic rhinitis (AR). MATERIALS AND METHODS: A 2-week, single-centered, randomized, double-blind, parallel group comparative clinical study was conducted on patients with AR. Following i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dakhale, Ganesh, Tathod, Yogesh, Patel, Seema, Pimpalkhute, Sonali, Raghute, Latesh, Khamkar, Ajita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242030/ https://www.ncbi.nlm.nih.gov/pubmed/28163538 http://dx.doi.org/10.4103/0976-500X.195901

Ejemplares similares

Comparison of Efficacy, Safety and Cost-effectiveness of Rupatadine and Olopatadine in Patients of Chronic Spontaneous Urticaria: A Randomized, Double-blind, Comparative, Parallel Group Trial
por: Dakhale, Ganesh N, et al.
Publicado: (2016)

Olopatadine hydrochloride and rupatadine fumarate in seasonal allergic rhinitis: A comparative study of efficacy and safety
por: Maiti, Rituparna, et al.
Publicado: (2011)

Efficacy and Safety of Oral Diclofenac Sustained release Versus Transdermal Diclofenac Patch in Chronic Musculoskeletal Pain: A Randomized, Open Label Trial
por: Shinde, Viraj Ashok, et al.
Publicado: (2017)

Efficacy and Safety of Rupatadine Fumarate Combined with Acupoint Application in Allergic Rhinitis Complicated with Diabetes
por: Liu, Yu, et al.
Publicado: (2022)

FUTURA STUDY-Evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent allergic rhinitis
por: de Godoy Mion, Olavo, et al.
Publicado: (2015)

Comparison of efficacy, safety, and cost-effectiveness of montelukast-levocetirizine and montelukast-fexofenadine in patients of allergic rhinitis: A randomized, double-blind clinical trial
por: Mahatme, Mohini Sachin, et al.
Publicado: (2016)

Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial
por: Marmouz, Farid, et al.
Publicado: (2011)

Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial [Corrigendum]
Publicado: (2015)

Clinically relevant effect of rupatadine 20 mg and 10 mg in seasonal allergic rhinitis: a pooled responder analysis
por: Mullol, Joaquim, et al.
Publicado: (2019)

Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops
por: Uchio, Eiichi
Publicado: (2008)

Rupatadine
por: Kaur, Manpreet, et al.
Publicado: (2013)

Rupatadine oral solution for 2–5-year-old children with allergic rhinitis: a safety, open-label, prospective study
por: Santamaría, Eva, et al.
Publicado: (2018)

Rupatadine Oral Solution Titration by Body Weight in Paediatric Patients Suffering from Allergic Rhinitis: A Population Pharmacokinetic Study
por: Santamaria, Eva, et al.
Publicado: (2021)

A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled study
por: Lukat, KF, et al.
Publicado: (2013)

Efficacy of Olopatadine versus Epinastine for Treating Allergic Conjunctivitis Caused by Japanese Cedar Pollen: A Double-Blind Randomized Controlled Trial
por: Fukushima, Atsuki, et al.
Publicado: (2014)

Topical Olopatadine Hydrochloride versus Ketotifen Fumarate for Allergic Conjunctivitis
por: Patel, Dharmistha, et al.
Publicado: (2018)

Long-term safety and efficacy of rupatadine in Japanese patients with perennial allergic rhinitis: a 52-week open-label clinical trial
por: Okubo, Kimihiro, et al.
Publicado: (2019)

Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis
por: Valero, Antonio, et al.
Publicado: (2020)

Comparison of olopatadine with ketotifen for allergic conjunctivitis: a meta-analysis study
por: Li, Shiyu, et al.
Publicado: (2023)

Rupatadine oral solution improves rhino-conjunctive symptoms control in children with 6-11 years weighing ≥25 kg with persistent allergic rhinitis
por: Izquierdo, Iñaki, et al.
Publicado: (2013)

Assessment of quality of life in epilepsy patients receiving anti-epileptic drugs in a tertiary care teaching hospital
por: Pimpalkhute, Sonali A., et al.
Publicado: (2015)

Investigation of the antiallergic activity of olopatadine on rhinitis induced by intranasal instillation of antigen in sensitized rats using thermography
por: Tamura, Tadafumi
Publicado: (2011)

Rupatadine to prevent local allergic reactions to sublingual allergy immunotherapy: a case series
por: Ellis, Anne K., et al.
Publicado: (2021)

The effectiveness of olopatadine hydrochloride eye drops for allergic conjunctivitis: Protocol for a systematic review
por: Zi, Yingxin, et al.
Publicado: (2020)

OLOPATADINE IN CHRONIC IDIOPATHIC URTICARIA
por: Godse, Kiran V
Publicado: (2009)

Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
por: Mizoguchi, Takanori, et al.
Publicado: (2017)

Comparison of effects of alcaftadine and olopatadine on conjunctival epithelium and eosinophil recruitment in a murine model of allergic conjunctivitis
por: Ono, Santa J, et al.
Publicado: (2011)

Efficacy and safety of So-Cheong-Ryong-Tang in treatment of perennial allergic rhinitis: study protocol for a double-blind, randomised, parallel-group, multicentre trial
por: Kim, Min-Hee, et al.
Publicado: (2017)

Dual systemic allergic rhinitis and local allergic rhinitis
por: Blanca, Miguel, et al.
Publicado: (2015)

Efficacy of rupatadine in reducing the incidence of dengue haemorrhagic fever in patients with acute dengue: A randomised, double blind, placebo-controlled trial
por: Malavige, Gathsaurie Neelika, et al.
Publicado: (2022)

Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design
por: Muñoz-Cano, Rosa, et al.
Publicado: (2013)

Effect of Nepeta bracteata Benth. on allergic rhinitis symptoms: A randomized double-blind clinical trial
por: Hajiheydari, Mohammad Reza, et al.
Publicado: (2017)

Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia – An Observational Real-World Clinical Study
por: Fifer, Simon, et al.
Publicado: (2023)

A topical microemulsion for the prevention of allergic rhinitis symptoms: results of a randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares study)
por: Ojeda, Pedro, et al.
Publicado: (2013)

Effects and safety of intranasal phototherapy for allergic rhinitis: Study protocol for a single-center, randomized, double-blind, parallel, placebo-controlled, investigator-initiated, pilot study
por: Kang, Jeongin, et al.
Publicado: (2020)

Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis
por: McLaurin, Eugene, et al.
Publicado: (2017)

Allergic rhinitis
por: Small, Peter, et al.
Publicado: (2011)

Allergic rhinitis
por: Small, Peter, et al.
Publicado: (2018)

Self-administered acupressure for allergic rhinitis: study protocol for a randomized, single-blind, non-specific controlled, parallel trial
por: Liang, Yaqun, et al.
Publicado: (2019)

Supplementation of Vitamin C Reduces Blood Glucose and Improves Glycosylated Hemoglobin in Type 2 Diabetes Mellitus: A Randomized, Double-Blind Study
por: Dakhale, Ganesh N., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_fkc7kk647072ioveph2j9ekmrd